Rocket Pharmaceuticals (RCKT) Goodwill & Intangibles (2018 - 2026)

Rocket Pharmaceuticals has reported Goodwill & Intangibles for 9 years, with the latest figure at $64.3 million in Q1 2026.

• Quarterly Goodwill & Intangibles changed 0.07% year-over-year to $64.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.3 million (changed 0.07% YoY) and the FY2025 annual result came in at $64.4 million, changed 0.0% from the prior year.
• Goodwill & Intangibles was little changed at $64.3 million in Q1 2026 per RCKT's latest filing, from $64.4 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $64.9 million in Q4 2022 and troughed at $30.8 million in Q1 2022.
• A 5-year average of $58.5 million and a median of $64.4 million in 2023 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles soared 110.69% in 2022, then decreased 0.88% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $64.9 million in 2022, then fell by 0.88% to $64.4 million in 2023, then changed by 0.0% to $64.4 million in 2024, then changed by 0.0% to $64.4 million in 2025, then slipped by 0.07% to $64.3 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $64.3 million, $64.4 million, and $64.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.